Review of “Promoting Transparency in Pharmaceutical Industry” – the myth of ‘scientific psychiatry’
Pharmaceutical industry sponsorship distorts clinical trial research and the medical literature.
Pharmaceutical industry sponsorship distorts clinical trial research and the medical literature.
For the release of its antidepressant Zoloft in the late 1990s and early 2000s, Pfizer orchestrated a ghostwriting program in which a medical communications company… Read More »Pharma Fraudulent Marketing – Zoloft – Ghost Writing
Still no validated causes, no cures, and no practical tools that actually help people labelled “mentally ill.”
In places that claim to offer care and healing for the mentally vulnerable, too many have instead found further violation.
The latest research from Australia delivers a stark, data-driven indictment of psychiatry’s primary “solution” for attention deficit hyperactivity disorder.
In this powerful Tucker Carlson interview, Laura Delano delivers a raw, firsthand indictment of modern psychiatry
In the Nineteenth century psychiatry promised a new dawn for mental health. Instead, it has delivered a perpetual night of symptom suppression, ever-expanding diagnoses, and a pharmaceutical profit machine that treats patients as repeat customers.
The men of the Rockefeller Foundation were interested in using psychiatry as part of their plans for worldwide ‘mental hygiene’ (eugenics and biological psychiatry). They… Read More »More on the ‘psychiatry is scientific’ myth
Most of what you see in ‘modern’ biological psychiatry is called the ‘neo-Kraepelin revolution’ and is based on the opinions of psychiatrist and eugenicist, Emil… Read More »The ‘psychiatry is scientific’ myth
…the most important part of a resident’s curriculum is the art and quasi-science of dealing drugs, i.e., prescription writing.
A January 2024 study using machine learning analysis of neuroscience findings failed to find any biomarkers for Major Depressive Disorder.
A recent study of almost 127,000 youths who were subject to Medicaid from a single US state found from 2015 to 2020 the rate of psychotropic polypharmacy had increased to 4.6% – affecting more than 5,800 individuals.